克羅米酚聯(lián)合人絕經(jīng)期促性腺激素治療小卵泡排卵的效果分析

打開文本圖片集

【摘 要】目的：臨床治療小卵泡排卵疾病實(shí)施克羅米酚聯(lián)合人絕經(jīng)期促性腺激素進(jìn)行治療，觀察分析克羅米酚聯(lián)合人絕經(jīng)期促性腺激素治療此種疾病的臨床治療效果。方法：使用不可計(jì)數(shù)法選取我院2020年2月至2021年3月期間治療小卵泡排卵患者共60例，將其分為兩組，對(duì)比兩組臨床療效。結(jié)果：（1）兩組患者在最大MFD、子宮內(nèi)膜平均厚度以及宮頸Insler分?jǐn)?shù)之比均無統(tǒng)計(jì)學(xué)差異（P>0.05），但是在MFD≥15數(shù)量上觀察組優(yōu)于對(duì)照組（P

【關(guān)鍵詞】克羅米酚；人絕經(jīng)期促性腺激素；小卵泡排卵；臨床治療效果

Analysis of the Effect of Clomiphene Combined with Human Menopausal Gonadotropin on Small Follicular Ovulation

CHANG Hairu

Fengrun District People’s Hospital of Tangshan， Hebei， Tangshan， Hebei 064000， China

【Abstract】Objective：Clinical treatment of small follicle ovulation disease implements clomiphene combined with human menopausal gonadotropin， to observe and analyze the clinical therapeutic effect of clomiphene combined with human menopausal gonadotropin on this disease. Methods：A total of 60 patients with small follicle ovulation treated in our hospital from February 2020 to March 2021 were selected using the non-counting method， and they were divided into two groups to compare the clinical efficacy. Results：（1） There was no significant difference in the ratio of maximum MFD， average endometrial thickness and cervical Insler score between the two groups（P>0.05）， but the observation group was better than the control group in terms of MFD≥15（P

【Key words】Clomiphene； Human menopausal gonadotropin； Small follicle ovulation； Clinical therapeutic effect

作為臨床排卵障礙疾病之一，卵泡發(fā)育不良主要是指優(yōu)勢(shì)的卵泡還沒有成長發(fā)育成熟（其直徑平均值≤18mm）便出現(xiàn)排卵情況，屬于不正常排卵，為此臨床將其此種情況又稱作為小卵泡排卵[1]。（剩余3343字）